Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:LCI

Lannett (LCI) Stock Price, News & Analysis

Lannett logo

About Lannett Stock (NYSE:LCI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.65
$2.51
52-Week Range
N/A
Volume
280,600 shs
Average Volume
92,067 shs
Market Capitalization
$7.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.

Receive LCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lannett and its competitors with MarketBeat's FREE daily newsletter.

LCI Stock News Headlines

Lucky Core Industries Ltd.
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
LANNETT SHARES UPDATE
Why Lannett (LCI) Stock Is Down Today
See More Headlines

LCI Stock Analysis - Frequently Asked Questions

Lannett Company, Inc. (NYSE:LCI) posted its quarterly earnings data on Wednesday, November, 3rd. The company reported ($1.08) earnings per share for the quarter, missing the consensus estimate of ($1.00) by $0.08. The firm had revenue of $101.53 million for the quarter, compared to analysts' expectations of $98.62 million.
Read the conference call transcript
.

Shares of Lannett reverse split before market open on Tuesday, February 7th 2023. The 1-4 reverse split was announced on Tuesday, February 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lannett investors own include Bristol-Myers Squibb (BMY), Akorn (AKRX), Micron Technology (MU), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), AT&T (T) and Bank of America (BAC).

Company Calendar

Last Earnings
11/03/2021
Today
5/16/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:LCI
Employees
810
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-231,620,000.00
Pretax Margin
-62.67%

Debt

Sales & Book Value

Annual Sales
$340.58 million
Price / Cash Flow
N/A
Book Value
($23.34) per share
Price / Book
N/A

Miscellaneous

Free Float
9,354,000
Market Cap
$7.38 million
Optionable
Optionable
Beta
0.95

Social Links

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:LCI) was last updated on 5/17/2025 by MarketBeat.com Staff
From Our Partners